Any statements contained in this presentation that do not describe historical facts, including statements about the beliefs and expectations of TransEnterix, Inc. (“TransEnterix,” "we" or "our"), may constitute forward-looking statements as that term is defined by the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expect," "anticipate," "future," "intend," "plan," "believe," "estimate," "confident" and similar statements. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties that may cause actual results to differ materially from expectations. Potential risks and uncertainties include the risks outlined in this presentation and TransEnterix’ filings with the U.S. Securities and Exchange Commission, including the benefits and opportunities of surgical robotics, whether the combined company formed as a result of the Sept. 2013 merger of TransEnterix and SafeStitch Medical, Inc. will be successful in 2014 and beyond, the success and market opportunity of our continuing and new product development efforts, including the SurgiBot system, the pace of adoption of our product technology by surgeons, the effect on our business of existing and new regulatory requirements, the outcome of coverage and reimbursement decisions by the government and third party payors, and other economic and competitive factors. We caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. 2 Cautionary Statement | 
